Fintel reports that on January 10, 2025, Cantor Fitzgerald initiated coverage of Voyager Therapeutics (NasdaqGS:VYGR) with a ...

Analysts at Cantor Fitzgerald initiated coverage on shares of Bright Minds Biosciences (NASDAQ:DRUG – Get Free Report) in a note issued to investors on Friday, MarketBeat.com reports. The brokerage ...

Cantor Fitzgerald initiated coverage on shares of Check Point Software Technologies (NASDAQ:CHKP – Free Report) in a research ...

Eric Johnston, Cantor Fitzgerald chief equity and macro strategist, joins 'Money Movers' to discuss Johnston's thesis for ...

Cantor Fitzgerald initiated coverage of Bright Minds Biosciences (DRUG) with an Overweight rating and no price target The company’s emerging ...

Cantor Fitzgerald analyst Jonathan Ruykhaver initiated coverage of SentinelOne (S) with an Overweight rating and $30 price target. Shares have ...

Cantor Fitzgerald is charged with violating antifraud and proxy provisions. Former Comtech CEO is charged with insider trading ahead of negative earnings. The Securities and Exchange Commission on ...

Cantor Equity Partners I, Inc. (Nasdaq: CEPO) (the "Company") announced today that it closed its initial public offering of 20,000,000 Class A ordinary shares at $10.00 per share. The shares began ...

Cantor Fitzgerald Equity Opportunity Fd earns a Low Process Pillar rating. The primary detractor from the rating is the fund's unimpressive long-term risk-adjusted performance. This can be seen in ...

Investors often prefer to invest in shares held by company insiders, as management is typically more aligned with the company’s success and shareholder interests. Currently, insiders own just 1.56% of ...

Cantor Equity Partners I, Inc. (Nasdaq: CEPO) (the "Company") announced today that it closed its initial public offering ...